The established cancer risks differ between MLH1, MSH2, MSH6, and PMS2 and this is reflected in the cancer incidences for PV carriers for the four genes, although this may also in part reflect ascertainment bias due to eligibility criteria for testing. This evidence concerns the gene MLH1 and cancer.